"The best biologics technology meeting in Europe."
- Rakesh D., Ph.D., VP, R&D, MedImmune
"The presentations were exceptional, covering an extraordinary array of antibody and antibody-alternative technologies. PEGS Europe is unparalleled in both scope and quality." - Kevin R., Ph.D., Scientist, Wellcome Trust Sanger Institute
"A great overview highlighting almost all aspects of antibody development of the current and next generation. Almost a perfect conference."
- Peter S., Ph.D., CSO, SuppreMol
"I have enjoyed this meeting very much and the quality of the talks has been very good. I also enjoyed our roundtable. It was a very engaged group and I thought the discussion went very well."
- Luis B., Ph.D., Scientific Director, Amgen, Inc.
Streamlining Protein Expression & Production
Lorenz Mayr, Ph.D., AstraZeneca
Current and Future Trends in Antibody Therapeutics
Paul W.H.I. Parren, Ph.D., Genmab B.V.
Protein Engineering for New Modes of Actions & New Targets
Andreas Plückthun, Ph.D., University of Zurich
Targeting Ion Channels
Tristan J. Vaughan, Ph.D., MedImmune Ltd.
Mechanically Refolding Proteins beyond Unboiling an Egg
Gregory A. Weiss, Ph.D., University of California, Irvine